Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum
« Previous
123456789101112
Next »

State Legislatures Become Battlegrounds for Biosimilars

Maryland is the latest state to consider whether to include additional requirements for substitution of biological products.
Apr 11, 2013
By: Patricia Van Arnum

Maryland is the latest state to consider whether to include additional requirements for substitution of biological products

Pfizer Issued Warning Letter for Italian Manufacturing Plant

Company is notified of GMP violations at facility in Catania, Italy.
Apr 11, 2013
By: Patricia Van Arnum

Company is notified of GMP violations at facility in Catania, Italy.

Navigating the Global Manufacturing Supply Chain

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
Apr 10, 2013
By: Patricia Van Arnum

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.

Pfizer Voluntarily Recalls Levoxyl

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.
Apr 8, 2013
By: Patricia Van Arnum

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.

Eli Lilly Considers Investment in US Insulin-Manufacturing Capacity

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.
Apr 8, 2013
By: Patricia Van Arnum

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.

Indian Supreme Court Rejects Patent for Glivec by Novartis

Ruling has implications for intellectual property protection for innovator drugs in India.
Apr 3, 2013
By: Patricia Van Arnum

Ruling has implications for intellectual property protection for innovator drugs in India.

The Plan by AstraZeneca CEO Pascal Soriot to Revitalize the Company

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.
Apr 3, 2013
By: Patricia Van Arnum

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.

GlaxoSmithKline Tops Industry Rankings for Access to Medicines

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.
Apr 3, 2013
By: Patricia Van Arnum

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.

Fine-Chemical Producers Make Targeted Investments

Contract API manufacturers proceed with select investment in capacity and service additions.
Apr 2, 2013
By: Patricia Van Arnum

Contract API manufacturers proceed with select investment in capacity and service additions.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here